SOPHiA GENETICS(SOPH)
$6.23-0.45 (-6.74%)
SOPH
SOPHiA GENETICS financials statements
$6.23
At close:-0.45 (-6.74%)
Want to see SOPH full AI Analyst Report?
SOPHiA GENETICS (SOPH) Ratios
145 Followers
SOPHiA GENETICS Ratios
SOPH's free cash flow for Q3 2026 was $-11.79M. For the 2026 fiscal year, SOPH's free cash flow was decreased by $-2.32M and operating cash flow was $-9.48M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.96 | 3.71 | 4.16 | 7.32 | 9.89 |
| Quick Ratio | 1.84 | 3.49 | 3.97 | 7.13 | 9.69 |
| Cash Ratio | 1.39 | 2.99 | 3.46 | 6.02 | 6.75 |
| Solvency Ratio | -0.60 | -0.92 | -1.29 | -1.87 | -1.56 |
| Operating Cash Flow Ratio | -0.75 | -1.60 | -1.36 | -2.61 | -2.03 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -17.23M | $ 40.59M | $ 93.33M | $ 152.55M | $ 238.08M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.39 | 0.19 | 0.09 | 0.07 | 0.04 |
| Debt-to-Equity Ratio | 1.34 | 0.31 | 0.12 | 0.08 | 0.05 |
| Debt-to-Capital Ratio | 0.57 | 0.24 | 0.11 | 0.08 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.50 | 0.12 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 3.47 | 1.61 | 1.36 | 1.22 | 1.16 |
| Debt Service Coverage Ratio | -14.25 | -27.17 | -119.14 | -127.13 | -105.48 |
| Interest Coverage Ratio | -15.57 | -34.80 | -127.26 | -137.44 | -108.65 |
| Debt to Market Cap | 0.15 | 0.07 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.00 | 0.49 | 0.30 | 0.27 | 0.25 |
| Net Debt to EBITDA | 0.11 | 0.99 | 1.50 | 1.78 | 2.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.88% | 67.42% | 68.80% | 65.71% | 62.35% |
| EBIT Margin | -95.68% | -91.08% | -124.91% | -182.81% | -180.10% |
| EBITDA Margin | -83.35% | -77.89% | -111.54% | -171.10% | -171.17% |
| Operating Profit Margin | -91.79% | -102.14% | -119.97% | -184.66% | -176.73% |
| Pretax Profit Margin | -101.57% | -94.01% | -125.85% | -184.16% | -181.72% |
| Net Profit Margin | -102.24% | -95.89% | -126.63% | -183.87% | -182.14% |
| Continuous Operations Profit Margin | -102.24% | -95.89% | -126.63% | -183.87% | -182.14% |
| Net Income Per EBT | 100.65% | 102.00% | 100.62% | 99.84% | 100.23% |
| EBT Per EBIT | 110.66% | 92.04% | 104.90% | 99.73% | 102.82% |
| Return on Assets (ROA) | -48.33% | -40.24% | -38.31% | -35.86% | -23.01% |
| Return on Equity (ROE) | -167.57% | -64.77% | -52.15% | -43.70% | -26.75% |
| Return on Capital Employed (ROCE) | -62.81% | -51.80% | -43.88% | -40.47% | -24.52% |
| Return on Invested Capital (ROIC) | -61.34% | -50.93% | -43.14% | -39.91% | -24.37% |
| Return on Tangible Assets | -61.93% | -49.48% | -44.13% | -39.06% | -24.20% |
| Earnings Yield | -25.05% | -30.94% | -25.90% | -66.23% | -9.45% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.17 | 7.50 | 4.10 | 5.91 | 5.71 |
| Payables Turnover | 5.54 | 10.99 | 8.63 | 7.51 | 6.52 |
| Inventory Turnover | 4.64 | 3.62 | 3.00 | 3.16 | 2.66 |
| Fixed Asset Turnover | 4.28 | 3.36 | 2.70 | 2.22 | 2.54 |
| Asset Turnover | 0.47 | 0.42 | 0.30 | 0.20 | 0.13 |
| Working Capital Turnover Ratio | 1.28 | 0.70 | 0.44 | 0.22 | 0.24 |
| Cash Conversion Cycle | 100.35 | 116.32 | 168.25 | 128.64 | 145.27 |
| Days of Sales Outstanding | 87.51 | 48.67 | 88.98 | 61.80 | 63.97 |
| Days of Inventory Outstanding | 78.69 | 100.86 | 121.59 | 115.41 | 137.31 |
| Days of Payables Outstanding | 65.86 | 33.21 | 42.32 | 48.57 | 56.01 |
| Operating Cycle | 166.21 | 149.53 | 210.57 | 177.22 | 201.28 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.56 | -0.65 | -0.75 | -1.09 | -1.05 |
| Free Cash Flow Per Share | -0.57 | -0.78 | -0.89 | -1.26 | -1.17 |
| Dividend Paid and CapEx Coverage Ratio | -66.22 | -5.24 | -5.27 | -6.75 | -8.69 |
| Capital Expenditure Coverage Ratio | -66.22 | -5.24 | -5.27 | -6.75 | -8.69 |
| Operating Cash Flow Coverage Ratio | -0.60 | -1.43 | -2.61 | -4.19 | -4.44 |
| Operating Cash Flow to Sales Ratio | -0.49 | -0.66 | -0.78 | -1.47 | -1.43 |
| Free Cash Flow Yield | -12.23% | -25.25% | -18.95% | -60.94% | -8.29% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.99 | -3.23 | -3.86 | -1.51 | -10.58 |
| Price-to-Sales (P/S) Ratio | 4.08 | 3.10 | 4.89 | 2.78 | 19.28 |
| Price-to-Book (P/B) Ratio | 6.69 | 2.09 | 2.01 | 0.66 | 2.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.17 | -3.96 | -5.28 | -1.64 | -12.07 |
| Price-to-Operating Cash Flow Ratio | -8.30 | -4.72 | -6.28 | -1.88 | -13.46 |
| Price-to-Earnings Growth (PEG) Ratio | -0.17 | 0.15 | 0.38 | -0.67 | -0.17 |
| Enterprise Value Multiple | -4.78 | -2.99 | -2.88 | 0.15 | -8.66 |
| Enterprise Value | 308.14M | 151.76M | 200.33M | -12.52M | 599.83M |
| EV to EBITDA | -4.78 | -2.99 | -2.88 | 0.15 | -8.66 |
| EV to Sales | 3.99 | 2.33 | 3.21 | -0.26 | 14.83 |
| EV to Free Cash Flow | -7.99 | -2.98 | -3.47 | 0.16 | -9.28 |
| EV to Operating Cash Flow | -8.11 | -3.54 | -4.12 | 0.18 | -10.35 |
| Tangible Book Value Per Share | 0.17 | 1.03 | 1.92 | 2.81 | 4.70 |
| Shareholders’ Equity Per Share | 0.70 | 1.47 | 2.34 | 3.12 | 4.98 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.02 | -0.01 | 0.00 | -0.00 |
| Revenue Per Share | 1.14 | 0.99 | 0.96 | 0.74 | 0.73 |
| Net Income Per Share | -1.17 | -0.95 | -1.22 | -1.36 | -1.33 |
| Tax Burden | 1.01 | 1.02 | 1.01 | 1.00 | 1.00 |
| Interest Burden | 1.06 | 1.03 | 1.01 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.43 | 0.53 | 0.59 | 0.74 | 0.66 |
| SG&A to Revenue | 1.10 | 1.17 | 0.85 | 1.17 | 1.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.25 | 0.24 | 0.29 | 0.21 |
| Income Quality | 0.48 | 0.70 | 0.62 | 0.80 | 0.79 |
Currency in USD

